Home > Riviste > Minerva Anestesiologica > Fascicoli precedenti > Minerva Anestesiologica 2015 November;81(11) > Minerva Anestesiologica 2015 November;81(11):1244-61

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Estratti
Permessi
Per citare questo articolo

 

REVIEWS   Freefree

Minerva Anestesiologica 2015 November;81(11):1244-61

Copyright © 2015 EDIZIONI MINERVA MEDICA

lingua: Inglese

Complications of immunosuppressive agents therapy in transplant patients

Reske A. P. 1, Reske A. W. 2, Metze M. 3

1 Fachkrankenhaus Coswig GmbH, Division of Anesthesiology and Intensive Care Medicine, Coswig, Germany; 2 Department of Anesthesiology and Intensive Care Medicine, University Hospital Leipzig, Leipzig, Germany; 3 Division of Cardiology and Angiology, Department of Internal Medicine, Neurology and Dermatology, University Hospital Leipzig, Leipzig, Germany


PDF


Solid organ transplantation remains the gold standard for the treatment of end-stage organ dysfunction and saves thousands of lives. Besides the progress of surgery, advances in understanding transplant physiology, immunology and the development of immunosuppressive drugs lead to improved short- and long-term survival. Transplantation is offered to an increasing number of patients with higher age and comorbidities. Approximately one third of organ recipients require hospital readmission after transplantation because of a multitude of clinical problems related to immunosuppressive therapy. We review the current knowledge on typical complications associated with immunosuppressants with emphasis on the intensivist’s perspective.

inizio pagina